BiomX Inc. (NYSEAMERICAN:PHGE) Short Interest Down 60.3% in February

BiomX Inc. (NYSEAMERICAN:PHGE) was the target of a large decline in short interest during the month of February. As of February 15th, there was short interest totalling 9,800 shares, a decline of 60.3% from the January 31st total of 24,700 shares. Based on an average daily trading volume, of 86,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.1% of the company’s stock are sold short.

Analysts Set New Price Targets

Separately, HC Wainwright reissued a “buy” rating and set a $2.00 price target on shares of BiomX in a report on Wednesday, January 8th.

BiomX Stock Performance

Shares of NYSEAMERICAN PHGE traded down $0.03 during trading on Friday, hitting $0.65. 40,479 shares of the company were exchanged, compared to its average volume of 75,523. BiomX has a 1 year low of $0.48 and a 1 year high of $8.55. The firm has a market capitalization of $11.82 million, a P/E ratio of -0.20 and a beta of 1.27.

About BiomX

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).